Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03602079
Title Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 Gene
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Klus Pharma Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Florida Cancer Specialists & Research Institute Sarasota Florida 34232 United States Details
Beth Israel Deaconess Medical Center Cancer Center Boston Massachusetts 02215 United States Details
Karmanos Cancer Institute Detroit Michigan 48201 United States Details
Clinical Research Alliance, Inc. Lake Success New York 11042 United States Details
Stephenson Cancer Center Oklahoma City Oklahoma 73104 United States Details
Providence Cancer Institute Portland Oregon 97213 United States Details
Mary Crowley Cancer Research Centers - Medical City Dallas Texas 75230 United States Details
The University of Texas MD Anderson Cancer Center Houston Texas 77030 United States Details
South Texas Accelerated Research Therapeutics, LLC (START) San Antonio Texas 78229 United States Details
Virginia Cancer Specialist Fairfax Virginia 22031 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field